More than 44,000 Vials of Procrit Recalled


Procrit is being recalled by Johnson & Johnson subsidiary Ortho Biotech. According to the company’s recall notice, the action is necessary because cracks in the necks of a small number of Procrit vials were discovered upon post-manufacturing inspection.


The Procrit recall involves approximately 44,292 vials of lot P114942A distributed between April 15, 2008 and July 17, 2008. The recalled Procrit vials were available in the following packaging configurations:

• Individual multi-dose vials 10,000 U/2mL; NDC #59676-312-00; Expiration date 12/10
• Cartons containing 4 multi-dose vials 10,000 U/2mL; NDC 59676-312-04; Expiration date 12/10

According to the recall notice, Procrit vials exhibiting even slight cracks may not maintain their sterile condition and should not be used for subcutaneous or intravenous injection. Procrit vials from the recalled lot should be promptly returned by contacting the returned goods service provider, at (800) 668-4391.
Procrit is an erythropoiesis-stimulating agent (ESA). ESAs are a...Continued

__________________
Sharon Grant
Editorial Team